Boron Phenylalanine-Modified Polydopamine Nanoparticles for Targeted Delivery of Danusertib in Non-Small Cell Lung Cancer.

Int J Nanomedicine · 2025 · PMC12223414 · PMID 40613040

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

During the treatment period, mice in the Sal and B-PDA groups showed a decreasing trend in body weight and poor overall condition, while mice in the Danu group maintained relatively stable body weight initially but started to decrease later on.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.